HomeCompareKIN vs ADC

KIN vs ADC: Dividend Comparison 2026

KIN yields 21.62% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADC wins by $98.3K in total portfolio value· pulled ahead in Year 9
10 years
KIN
KIN
● Live price
21.62%
Share price
$9.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.6K
Annual income
$7,983.46
Full KIN calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — KIN vs ADC

📍 ADC pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKINADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KIN + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KIN pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIN
Annual income on $10K today (after 15% tax)
$1,837.84/yr
After 10yr DRIP, annual income (after tax)
$6,785.94/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ADC beats the other by $61,891.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIN + ADC for your $10,000?

KIN: 50%ADC: 50%
100% ADC50/50100% KIN
Portfolio after 10yr
$129.8K
Annual income
$44,390.38/yr
Blended yield
34.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

KIN
No analyst data
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIN buys
0
ADC buys
0
No recent congressional trades found for KIN or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKINADC
Forward yield21.62%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$80.6K$178.9K
Annual income after 10y$7,983.46$80,797.29
Total dividends collected$47.7K$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: KIN vs ADC ($10,000, DRIP)

YearKIN PortfolioKIN Income/yrADC PortfolioADC Income/yrGap
1$12,862$2,162.16$10,990$580.36+$1.9KKIN
2$16,362$2,599.07$12,301$860.26+$4.1KKIN
3$20,597$3,089.91$14,104$1,298.62+$6.5KKIN
4$25,674$3,635.27$16,691$2,008.16+$9.0KKIN
5$31,706$4,234.91$20,580$3,205.09+$11.1KKIN
6$38,813$4,887.76$26,754$5,330.02+$12.1KKIN
7$47,122$5,591.96$37,196$9,345.14+$9.9KKIN
8$56,765$6,344.91$56,244$17,523.09+$521.00KIN
9← crossover$67,882$7,143.35$94,286$35,736.21$26.4KADC
10$80,618$7,983.46$178,949$80,797.29$98.3KADC

KIN vs ADC: Complete Analysis 2026

KINStock

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

Full KIN Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this KIN vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIN vs SCHDKIN vs JEPIKIN vs OKIN vs KOKIN vs MAINKIN vs NNNKIN vs EPRTKIN vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.